The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer
Open accessAbstract
BACKGROUND: We have recently identified down-regulated microRNAs including miR-145 and miR-133a in bladder cancer (BC). The aim of this study is to determine the genes targeted by miR-145, which is the most down-regulated microRNA in BC. METHODS: We focused on fascin homologue 1 (FSCN1) from the gene expression profile in miR-145 transfectant. The luciferase assay was used to confirm the actual binding sites of FSCN1 mRNA. Cell viability was evaluated by cell growth, wound-healing, and matrigel invasion assays. BC specimens were subjected to immunohistochemistry of FSCN1 and in situ hybridisation of miR-145. RESULTS: The miR-133a as well as miR-145 had the target sequence of FSCN1 mRNA by the database search, and both microRNAs repressed the mRNA and protein expression of FSCN1. The luciferase assay revealed that miR-145 and miR-133a were directly bound to FSCN1 mRNA. Cell viability was significantly inhibited in miR-145, miR-133a, and si-FSCN1 transfectants. In situ hybridisation revealed that miR-145 expression was markedly repressed in the tumour lesion in which FSCN1 was strongly stained. The immunohistochemical score of FSCN1 in invasive BC (n=46) was significantly higher than in non-invasive BC (n=20) (P=0.0055). CONCLUSION: Tumour suppressive miR-145 and miR-133a directly control oncogenic FSCN1 in BC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
Identification of Novel Genes Coding for Small Expressed RNAs
Lagos-Quintana, M., Rauhut, R., Lendeckel, W., & Tuschl, T. (2001) · Science · doi:10.1126/science.1064921 · Cited by 4,956
Bandrés, E., Cubedo, E., Agirre, X., Malumbres, R., Zárate, R., Ramírez, N., Abajo, A., Navarro, A., Moreno, I., Monzó, M., et al. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-29 · Cited by 884
p53 represses c-Myc through induction of the tumor suppressor miR-145
Sachdeva, M., Zhu, S., Wu, F., Wu, H., Walia, V., Kumar, S., Elble, R., Watabe, K., & Mo, Y.-Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808042106 · Cited by 841
Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue
Wong, T.-S., Liu, X.-B., Wong, B. Y.-H., Ng, R. W.-M., Yuen, A. P.-W., & Wei, W. I. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0666 · Cited by 750
Wang, X., Tang, S., Le, S.-Y., Lu, R., Rader, J. S., Meyers, C., & Zheng, Z.-M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002557 · Cited by 741
International Union Against Cancer (UICC)
Turner, B. (2012) · The Statesman’s Yearbook · doi:10.1007/978-1-349-59541-9_43 · Cited by 720
MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death
Schickel, R., Boyerinas, B., Park, S.-M., & Peter, M. E. (2008) · Oncogene · doi:10.1038/onc.2008.274 · Cited by 719
Slaby, O., Svoboda, M., Fabian, P., Smerdova, T., Knoflickova, D., Bednarikova, M., Nenutil, R., & Vyzula, R. (2007) · Oncology · doi:10.1159/000113489 · Cited by 682
Szafranska, A. E., Davison, T. S., John, J., Cannon, T., Sipos, B., Maghnouj, A., Labourier, E., & Hahn, S. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210228 · Cited by 664
Widespread deregulation of microRNA expression in human prostate cancer
Ozen, M., Creighton, C. J., Ozdemir, M., & Ittmann, M. (2008) · Oncogene · doi:10.1038/sj.onc.1210809 · Cited by 634
In situ detection of miRNAs in animal embryos using LNA-modified oligonucleotide probes
Kloosterman, W. P., Wienholds, E., de Bruijn, E., Kauppinen, S., & Plasterk, R. H. A. (2006) · Nature Methods · doi:10.1038/nmeth843 · Cited by 599
Altered MicroRNA Expression Confined to Specific Epithelial Cell Subpopulations in Breast Cancer
Sempere, L. F., Christensen, M., Silahtaroglu, A., Bak, M., Heath, C. V., Schwartz, G., Wells, W., Kauppinen, S., & Cole, C. N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-5019 · Cited by 574
Urine Markers for Bladder Cancer Surveillance: A Systematic Review
van Rhijn, B. W. G., van der Poel, H. G., & van der Kwast, T. H. (2005) · European Urology · doi:10.1016/j.eururo.2005.03.014 · Cited by 530
Diagnostic and Prognostic MicroRNAs in Stage II Colon Cancer
Schepeler, T., Reinert, J. T., Ostenfeld, M. S., Christensen, L. L., Silahtaroglu, A. N., Dyrskjøt, L., Wiuf, C., Sørensen, F. J., Kruhøffer, M., Laurberg, S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6110 · Cited by 492
Role of fascin in filopodial protrusion
Vignjevic, D., Kojima, S.-I., Aratyn, Y., Danciu, O., Svitkina, T., & Borisy, G. G. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200603013 · Cited by 484
Maitra, A., Adsay, N. V., Argani, P., Iacobuzio-Donahue, C., De Marzo, A., Cameron, J. L., Yeo, C. J., & Hruban, R. H. (2003) · Modern Pathology · doi:10.1097/01.mp.0000086072.56290.fb · Cited by 429
MicroRNA-1 and microRNA-133a expression are decreased during skeletal muscle hypertrophy
McCarthy, J. J., & Esser, K. A. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00932.2006 · Cited by 423
Identification of novel microRNA targets based on microRNA signatures in bladder cancer
Ichimi, T., Enokida, H., Okuno, Y., Kunimoto, R., Chiyomaru, T., Kawamoto, K., Kawahara, K., Toki, K., Kawakami, K., Nishiyama, K., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24390 · Cited by 404
Self-citationFriedman, J. M., Liang, G., Liu, C.-C., Wolff, E. M., Tsai, Y. C., Ye, W., Zhou, X., & Jones, P. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3114 · Cited by 382
Childs, G., Fazzari, M., Kung, G., Kawachi, N., Brandwein-Gensler, M., McLemore, M., Chen, Q., Burk, R. D., Smith, R. V., Prystowsky, M. B., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080731 · Cited by 364
Micro RNA 145 Targets the Insulin Receptor Substrate-1 and Inhibits the Growth of Colon Cancer Cells
Shi, B., Sepp-Lorenzino, L., Prisco, M., Linsley, P., deAngelis, T., & Baserga, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702806200 · Cited by 353
Fascins, and their roles in cell structure and function
Kureishy, N., Sapountzi, V., Prag, S., Anilkumar, N., & Adams, J. C. (2002) · BioEssays · doi:10.1002/bies.10070 · Cited by 328
Decreased Expression of MicroRNA-143 and -145 in Human Gastric Cancers
Takagi, T., Iio, A., Nakagawa, Y., Naoe, T., Tanigawa, N., & Akao, Y. (2009) · Oncology · doi:10.1159/000218166 · Cited by 287
Vignjevic, D., Schoumacher, M., Gavert, N., Janssen, K.-P., Jih, G., Laé, M., Louvard, D., Ben-Ze'ev, A., & Robine, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0929 · Cited by 277
Roles of fascin in human carcinoma motility and signaling: Prospects for a novel biomarker?
Hashimoto, Y., Skacel, M., & Adams, J. C. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.05.004 · Cited by 275
MicroRNA profile analysis of human prostate cancers
Tong, A. W., Fulgham, P., Jay, C., Chen, P., Khalil, I., Liu, S., Senzer, N., Eklund, A. C., Han, J., & Nemunaitis, J. (2009) · Cancer Gene Therapy · doi:10.1038/cgt.2008.77 · Cited by 271
Clinicopathological Significance of microRNA-31, -143 and -145 Expression in Colorectal Cancer
Wang, C.-J., Zhou, Z.-G., Wang, L., Yang, L., Zhou, B., Gu, J., Chen, H.-Y., & Sun, X.-F. (2009) · Disease Markers · doi:10.1155/2009/921907 · Cited by 223
Wong, T., Liu, X., Chung‐Wai Ho, A., Po‐Wing Yuen, A., Wai‐Man Ng, R., & Ignace Wei, W. (2008) · International Journal of Cancer · doi:10.1002/ijc.23583 · Cited by 188
miR-145 inhibits breast cancer cell growth through RTKN
Zhao (2009) · International Journal of Oncology · doi:10.3892/ijo_00000275 · Cited by 179
Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer
Pelosi, G., Pastorino, U., Pasini, F., Maissoneuve, P., Fraggetta, F., lannucci, A., Sonzogni, A., De Manzoni, G., Terzi, A., Durante, E., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600731 · Cited by 174
Uncovering Growth-Suppressive MicroRNAs in Lung Cancer
Liu, X., Sempere, L. F., Galimberti, F., Freemantle, S. J., Black, C., Dragnev, K. H., Ma, Y., Fiering, S., Memoli, V., Li, H., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1355 · Cited by 173
Targeting lentiviral vectors to specific cell types in vivo
Yang, L., Bailey, L., Baltimore, D., & Wang, P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604993103 · Cited by 161
MicroRNA-143 as a Tumor Suppressor for Bladder Cancer
Lin, T., Dong, W., Huang, J., Pan, Q., Fan, X., Zhang, C., & Huang, L. (2009) · Journal of Urology · doi:10.1016/j.juro.2008.10.149 · Cited by 159
A Joinpoint regression analysis of long‐term trends in cancer mortality in Japan (1958–2004)
Qiu, D., Katanoda, K., Marugame, T., & Sobue, T. (2008) · International Journal of Cancer · doi:10.1002/ijc.23911 · Cited by 132
Cell-Matrix Adhesions Differentially Regulate Fascin Phosphorylation
Adams, J. C., Clelland, J. D., Collett, G. D. M., Matsumura, F., Yamashiro, S., & Zhang, L. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.12.4177 · Cited by 122
Darnel, A. D., Behmoaram, E., Vollmer, R. T., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1789 · Cited by 101
Fascin-1 expression in papillary and invasive urothelial carcinomas of the urinary bladder
Tong, G., Yee, H. T., Chiriboga, L. A., Hernandez, O. J., & Waisman, J. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.05.005 · Cited by 80
Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma
Zhang, H., Xu, L., Xiao, D., Xie, J., Zeng, H., Cai, W., Niu, Y., Yang, Z., Shen, Z.-Y., & Li, E.-M. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.032730 · Cited by 74
Sugimoto, T., Seki, N., Shimizu, S., Kikkawa, N., Tsukada, J., Shimada, H., Sasaki, K., Hanazawa, T., Okamoto, Y., & Hata, A. (2008) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20626 · Cited by 68
Self-citationFascin Determination in Urothelial Carcinomas of the Urinary Bladder: A Marker of Invasiveness
Karasavvidou, F., Barbanis, S., Pappa, D., Moutzouris, G., Tzortzis, V., Melekos, M. D., & Koukoulis, G. Κ. (2008) · Archives of Pathology & Laboratory Medicine · doi:10.5858/132.12.1912 · Cited by 31
Soukup, V., Babjuk, M., Duskova, J., Pešl, M., Szakáczová, M., Zámečník, L., & Dvořáček, J. (2008) · Urologia Internationalis · doi:10.1159/000132700 · Cited by 29
Cited by
Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review)
ALLEGRA, A., ALONCI, A., CAMPO, S., PENNA, G., PETRUNGARO, A., GERACE, D., & MUSOLINO, C. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1647 · Cited by 359
MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis
Xu, Q., Liu, L.-Z., Qian, X., Chen, Q., Jiang, Y., Li, D., Lai, L., & Jiang, B.-H. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr730 · Cited by 284
The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer
Yoshino, H., Chiyomaru, T., Enokida, H., Kawakami, K., Tatarano, S., Nishiyama, K., Nohata, N., Seki, N., & Nakagawa, M. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.23 · Cited by 273
Self-citationlincRNA-RoR and miR-145 Regulate Invasion in Triple-Negative Breast Cancer via Targeting ARF6
Eades, G., Wolfson, B., Zhang, Y., Li, Q., Yao, Y., & Zhou, Q. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0251 · Cited by 271
Genistein Inhibits Prostate Cancer Cell Growth by Targeting miR-34a and Oncogenic HOTAIR
Chiyomaru, T., Yamamura, S., Fukuhara, S., Yoshino, H., Kinoshita, T., Majid, S., Saini, S., Chang, I., Tanaka, Y., Enokida, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070372 · Cited by 266
Self-citation
Metadata
- Authors
- Chiyomaru, T., Enokida, H., Tatarano, S., Kawahara, K., Uchida, Y., Nishiyama, K., Fujimura, L., Kikkawa, N., Seki, N., & Nakagawa, M.
- Venue
- British Journal of Cancer
- Published
- 2010-02-16
- Volume
- 102
- Issue
- 5
- Pages
- 883-891
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2114557056
- Cited by
- 325
- References
- 45
- FWCI
- 10.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.